Evidence map›Paper›PMID 42563199›Full record

ArticleArthroplasty (London, England)2026

Long-term use of drugs used for knee osteoarthritis and their association with primary arthroplasty: a nested case-control study.

Sara Rodríguez-Martín, Encarnación Fernández-Antón, Gabriela Alonso-Martínez, Miguel Gil, Antonio Rodríguez-Miguel, Nina Martínez, Josep Vergés, Francisco J de Abajo

Abstract read
In one paragraph

Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara Rodríguez-MartínDepartment of Biomedical Sciences (Pharmacology), School of Medicine and Health Sciences, University of Alcalá (IRYCIS), Alcalá de Henares, Madrid, 28805, Spain.
Encarnación Fernández-AntónDepartment of Biomedical Sciences (Pharmacology), School of Medicine and Health Sciences, University of Alcalá (IRYCIS), Alcalá de Henares, Madrid, 28805, Spain.
Gabriela Alonso-MartínezDepartment of Biomedical Sciences (Pharmacology), School of Medicine and Health Sciences, University of Alcalá (IRYCIS), Alcalá de Henares, Madrid, 28805, Spain.
Miguel GilDivision of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, 28022, Spain.
Antonio Rodríguez-MiguelDepartment of Biomedical Sciences (Pharmacology), School of Medicine and Health Sciences, University of Alcalá (IRYCIS), Alcalá de Henares, Madrid, 28805, Spain.
Nina MartínezOsteoarthritis Foundation International, Barcelona, 08006, Spain.
Josep VergésOsteoarthritis Foundation International, Barcelona, 08006, Spain.
Francisco J de AbajoDepartment of Biomedical Sciences (Pharmacology), School of Medicine and Health Sciences, University of Alcalá (IRYCIS), Alcalá de Henares, Madrid, 28805, Spain. francisco.abajo@uah.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKnee osteoarthritis is a highly prevalent condition that eventually ends up in arthroplasty at advanced stages. It is unknown whether the prolonged use of drugs for its symptomatic treatment, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, non-opioid analgesics, and symptomatic slow-acting drugs for osteoarthritis (SYSADOAs), has an impact on the risk of arthroplasty. The purpose of this study was to assess whether long-term use of different medications prescribed for the symptomatic treatment of knee osteoarthritis is associated with the risk of undergoing surgical joint replacement compared with short-term use.

designA case-control study nested in a cohort of 264,014 patients with a recorded diagnosis of knee osteoarthritis was carried out in BIFAP, a Spanish primary healthcare database. From this cohort, we identified 15,892 cases of primary knee arthroplasty and matched them with up to 3 controls on age, sex, healthcare district, and index date using risk-set sampling. Through a conditional logistic regression, we computed the adjusted odds ratios (AOR) and 95% confidence intervals (95% CI) associated with durations of treatment 1-3, > 3-5, and > 5 years in comparison with < 1 year within the same pharmacological class. A test for trend was carried out.

resultsA trend to an increased risk of arthroplasty was found as treatment duration of NSAIDs increases, while no such trend was observed with SYSADOAs or analgesics. Patients using NSAIDs for more than 5 years showed an AOR of 2.35 (2.10-2.63) as compared to < 1 year. Both males and females, and subjects younger and older than 70 years old, shared this pattern.

conclusionsThis observational study shows that the prolonged use of NSAIDs in patients with knee osteoarthritis is associated with an increased risk of arthroplasty, while residual confounding by OA severity cannot be excluded. Results from SYSADOAs, opioids, and non-opioid analgesics are consistent with no association.

Indexed as

Knee arthroplastyKnee osteoarthritisNested case-control studyNon-steroidal anti-inflammatory drugs (NSAIDs)PharmacoepidemiologyReal-world dataSymptomatic slow-acting drugs for osteoarthritis (SYSADOAs)

Identifiers

PMID42563199
PMCPMC13450516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.